iTonic vs Nexalin Technology
ITOC and NXL side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ITOC and NXL compare
Nexalin Technology grew revenue faster over the last twelve months (76.7% versus 16.7% for iTonic).
iTonic keeps more of each dollar of sales as profit, with a net margin of −975% compared with −3381% at Nexalin Technology.
iTonic scores higher on the StockData Score (6 against 3 for Nexalin Technology), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ITOC | NXL |
|---|---|---|
| Size and price | ||
| Market cap | – | $1.2M |
| Share price | $1.98 | $1.48 |
| Change, 1 year | −79.0% | −96.1% |
| Beta (5Y) | 1.35 | 1.78 |
| Employees | 42 | 8 |
| StockData Score | ||
| Total score | 6 (better) | 3 |
| Valuation score | 0 | 1 (better) |
| Growth score | 1 | 2 (better) |
| Performance score | 0 | 0 |
| Health score | 5 (better) | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 4.4× |
| P/B | – | 4.7× |
| Fair value | – | $1.77 |
| Margin of safety | – | 16.5% |
| Growth | ||
| Revenue growth (TTM) | 16.7% | 76.7% (better) |
| Profitability | ||
| Gross margin | 62.6% | 82.4% (better) |
| Operating margin | −992% (better) | −3386% |
| Net margin | −975% (better) | −3381% |
| FCF margin | −619% | – |
| Return on equity | −36.0% (better) | −373% |
| Return on invested capital | −35.8% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −179.0× |
| Current ratio | 17.39 (better) | 0.69 |
| Altman Z-score | – | −51.95 |
| Piotroski F-score | 2 | 5 (better) |
| Dividends and buybacks | ||
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | – | 3.4% |
| Held by insiders | 45.2% | – |
| Short interest, % of float | 0.04% | – |
Go deeper
- ITOC stock overview
- ITOC income statement
- ITOC valuation and score
- NXL stock overview
- NXL income statement
- NXL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.